Propel Bio Management, LLC Abeona Therapeutics Inc. Transaction History
Propel Bio Management, LLC
- $154 Billion
- Q2 2024
A detailed history of Propel Bio Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 1,248,044 shares of ABEO stock, worth $8 Million. This represents 3.43% of its overall portfolio holdings.
Number of Shares
1,248,044Holding current value
$8 Million% of portfolio
3.43%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
57Shares Held
28.6MCall Options Held
827KPut Options Held
44.5K-
Suvretta Capital Management, LLC New York, NY3.69MShares$23.6 Million0.65% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.47MShares$22.2 Million0.98% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$20.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.68MShares$17.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$12.5 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $38.1M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...